$RPRX News

Forget Biotech's Binary Bets: This Dividend Stock Collects Royalties on Blockbusters Instead

Missed Royalty Pharma's Rally? Here's The Case Holders Backed

3 Reasons Royalty Pharma Is a Dividend Stock You Never Have to Sell

Royalty Pharma declares fourth quarter 2026 dividend

If You Invested $1000 In Royalty Pharma Stock 15 Years Ago, You Would Have This Much Today

Royalty Pharma to announce third quarter 2026 financial results on November 4, 2026

Why Royalty Pharma (RPRX) is Poised to Beat Earnings Estimates Again

Morgan Stanley Maintains Overweight on Royalty Pharma, Raises Price Target to $67

If You Invested $100 In Royalty Pharma Stock 10 Years Ago, You Would Have This Much Today

Royalty Pharma Eyes AI, China Growth While Navigating Biopharma Policy Shifts

Is Buying Royalty Pharma Stock a Safer Way to Bet on Revolution Medicines?

Royalty Pharma plc (RPRX) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Royalty Pharma (RPRX) Stock Looks Richly Priced After Its 136% Run

Royalty Pharma (RPRX) Could Be 10% Undervalued As Conference Spotlight Returns

Royalty Pharma announces $7.5 million gift to Blood Cancer United to expand Therapy Acceleration Program

Blood Cancer United Announces $7.5 Million Gift From Royalty Pharma to Expand Therapy Acceleration Program

Royalty Pharma plc (RPRX) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Royalty Pharma to present at upcoming investor conferences

If You Invested $1000 In Royalty Pharma Stock 15 Years Ago, You Would Have This Much Today

TD Cowen Maintains Buy on Royalty Pharma, Raises Price Target to $68